Hi E, The past year witnessed a substantial influx of investment into the neuroscience sector, culminating in several high-value deals during Q4 of 2023. The trend continues into this year, with several companies aiming to delve deeper into neuroscience and psychiatric disease. What lies ahead? Don't miss our panel of leading experts at the Fierce Biotech Summit held in Boston on September 30 - October 1st as they examine emerging trends, breakthroughs, and new disease targets, offering invaluable insights into the future of neuropharmaceutical research and development. Our Expert Panelists Include: Moderated by: Fraiser Kansteiner, Staff Writer, Fierce PharmaBlake Mandell, Co-Founder and CEO, Transcend Therapeutics Sara Kenkare-Mitra, Ph.D., President and Head of R&D, AlectorKabir Nath, CEO, Compass PathwaysCraig Thompson, CEO, Cerevance VIEW THE FULL AGENDA>> This is your last chance to save $500 and receive exclusive Fierce gifts! Register now, the Early Bird Rate Ends Friday, Aug 9th. Bring your team and save up to 25%. Contact Us to learn more. |
